Literature DB >> 16239381

Immunological control of tuberculosis: role of tumour necrosis factor and more.

S Stenger1.   

Abstract

Therapy of autoimmune diseases with tumour necrosis factor (TNF) neutralising agents has provided a unique opportunity to learn about the significance of TNF in the maintenance of latent bacterial infections in humans. The remarkably high incidence of tuberculosis in patients treated with TNF antagonists raises the intriguing question about the physiological role of TNF in maintaining the lifelong latency of tubercle bacilli in granulomas in infected patients. Basic research during the past decade(s) combined with thoughtful observations in human subjects with tuberculosis and autoimmune diseases has provided several potential explanations for the recurrence of tuberculosis if TNF supply is withdrawn. TNF is involved in at least four key functions that contribute towards beneficial effects on the symptoms of autoimmune disorders on the one hand, and the attenuation of immune responses against Mycobacterium tuberculosis on the other hand. These are outlined in this review: induction of apoptosis, maturation of dendritic cells, activation of antimicrobial activity in macrophages, and orchestration of leucocyte movement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239381      PMCID: PMC1766911          DOI: 10.1136/ard.2005.042531

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  90 in total

1.  Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

Authors:  T B Geijtenbeek; R Torensma; S J van Vliet; G C van Duijnhoven; G J Adema; Y van Kooyk; C G Figdor
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

Review 2.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Antigen presentation in the lung.

Authors:  P G Holt
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

4.  Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages.

Authors:  J Keane; H G Remold; H Kornfeld
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

5.  Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

Authors:  P C Taylor; A M Peters; E Paleolog; P T Chapman; M J Elliott; R McCloskey; M Feldmann; R N Maini
Journal:  Arthritis Rheum       Date:  2000-01

6.  In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.

Authors:  H M Lorenz; M Grünke; T Hieronymus; C Antoni; H Nüsslein; T F Schaible; B Manger; J R Kalden
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

7.  IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis.

Authors:  D Förtsch; M Röllinghoff; S Stenger
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

8.  Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction.

Authors:  D M Lewinsohn; A L Briden; S G Reed; K H Grabstein; M R Alderson
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

9.  Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.

Authors:  D M Lewinsohn; L Zhu; V J Madison; D C Dillon; S P Fling; S G Reed; K H Grabstein; M R Alderson
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

10.  Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology.

Authors:  V P Mohan; C A Scanga; K Yu; H M Scott; K E Tanaka; E Tsang; M M Tsai; J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

View more
  44 in total

Review 1.  The roles of microRNAs on tuberculosis infection: meaning or myth?

Authors:  Harapan Harapan; Fitra Fitra; Ichsan Ichsan; Mulyadi Mulyadi; Paolo Miotto; Nabeeh A Hasan; Marta Calado; Daniela M Cirillo
Journal:  Tuberculosis (Edinb)       Date:  2013-08-15       Impact factor: 3.131

2.  [Centrofacial granulomatous inflammation].

Authors:  J Maetzke; R Hinrichs; A Sigge; K Scharffetter-Kochanek
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

3.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

Review 4.  Insights into early mycobacterial pathogenesis from the zebrafish.

Authors:  Robin Lesley; Lalita Ramakrishnan
Journal:  Curr Opin Microbiol       Date:  2008-06-19       Impact factor: 7.934

5.  Role of QuantiFERON-TB Gold antigen-specific IL-1β in diagnosis of active tuberculosis.

Authors:  Maddineni Prabhavathi; Basirudeen Syed Ahamed Kabeer; Anbarasu Deenadayalan; Alamelu Raja
Journal:  Med Microbiol Immunol       Date:  2014-12-11       Impact factor: 3.402

6.  Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha.

Authors:  Osman Elbek; Meral Uyar; Neriman Aydin; Sermin Börekçi; Nazan Bayram; Hasan Bayram; Oner Dikensoy
Journal:  Clin Rheumatol       Date:  2008-12-04       Impact factor: 2.980

7.  Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment.

Authors:  James M Young; Ifedayo M O Adetifa; Martin O C Ota; Jayne S Sutherland
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

8.  Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.

Authors:  Steven G Smith; Maeve K Lalor; Patricia Gorak-Stolinska; Rose Blitz; Natalie E R Beveridge; Andrew Worth; Helen McShane; Hazel M Dockrell
Journal:  BMC Immunol       Date:  2010-07-07       Impact factor: 3.615

9.  Tumour necrosis factor receptors and apoptosis of alveolar macrophages during early infection with attenuated and virulent Mycobacterium bovis.

Authors:  Michele F Rodrigues; Caio C S Alves; Bárbara B M Figueiredo; Alice B Rezende; Sabine Wohlres-Viana; Vânia Lúcia da Silva; Marco Antônio Machado; Henrique C Teixeira
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

10.  Attenuation of toll-like receptor expression and function in latent tuberculosis by coexistent filarial infection with restoration following antifilarial chemotherapy.

Authors:  Subash Babu; Sajid Q Bhat; N Pavan Kumar; R Anuradha; Paul Kumaran; P G Gopi; C Kolappan; V Kumaraswami; Thomas B Nutman
Journal:  PLoS Negl Trop Dis       Date:  2009-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.